Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-025769

Vanda Pharmaceuticals Inc. · VNDA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paolo Baroldi
Officer — SVP & Chief Medical Officer
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347178

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 10, 2015M12,500—A34,485D
Common StockF1Mar 10, 2015M5,000—A39,485D
Common StockF3Mar 10, 2015S8,940$10.54D30,545D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1,F4,F5—Mar 10, 2015M12,500D——Common Stock12,50025,000D
Restricted Stock UnitF1,F6,F5—Mar 10, 2015M5,000D——Common Stock5,00015,000D

Explanation of responses